The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global PCR-based Enteric Disease Testing Market Research Report 2024

Global PCR-based Enteric Disease Testing Market Research Report 2024

Publishing Date : May, 2024

License Type :
 

Report Code : 1995090

No of Pages : 106

Synopsis
The global PCR-based Enteric Disease Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PCR-based Enteric Disease Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PCR-based Enteric Disease Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for PCR-based Enteric Disease Testing in Clostridium Difficile is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of PCR-based Enteric Disease Testing include Thermo Fisher Scientific, Vela Diagnostics, CorisBioconcept, Meridian Life Science, Bio-Rad Laboratories, Abbott (ALERE), bioMerieux SA, Trinity Biotech and DiaSorin Molecular, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PCR-based Enteric Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCR-based Enteric Disease Testing.
Report Scope
The PCR-based Enteric Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PCR-based Enteric Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PCR-based Enteric Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Vela Diagnostics
CorisBioconcept
Meridian Life Science
Bio-Rad Laboratories
Abbott (ALERE)
bioMerieux SA
Trinity Biotech
DiaSorin Molecular
Etta Healthcare (Ovagene Oncology)
ExcitePCR (PositiveID Corporation)
Flow Alliance
Fluid-Screen
FluimediX
Fluxergy
Focus Diagnostics (DiaSorin Molecular)
Future Horizon Scientific
Genalyte
GeneFluidics
GenSpeed Biotech
Gulf Bio Analytical
Hahn-Schickard
Helvoet
HemoCue
Danaher
IDEX Health&Science
iLine Microsystems
Inflammatix
Segment by Type
Analyzers/Instruments
Kits/Panels
Segment by Application
Clostridium Difficile
Campylobacteriosis
Cholera
E. coli Infection
H. pylori Infection
Salmonellosis
Shigellosis
Rotavirus Infection
Norovirus Infection
Parasitic Enteric Disease
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PCR-based Enteric Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Analyzers/Instruments
1.2.3 Kits/Panels
1.3 Market by Application
1.3.1 Global PCR-based Enteric Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clostridium Difficile
1.3.3 Campylobacteriosis
1.3.4 Cholera
1.3.5 E. coli Infection
1.3.6 H. pylori Infection
1.3.7 Salmonellosis
1.3.8 Shigellosis
1.3.9 Rotavirus Infection
1.3.10 Norovirus Infection
1.3.11 Parasitic Enteric Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PCR-based Enteric Disease Testing Market Perspective (2019-2030)
2.2 PCR-based Enteric Disease Testing Growth Trends by Region
2.2.1 Global PCR-based Enteric Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PCR-based Enteric Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 PCR-based Enteric Disease Testing Market Dynamics
2.3.1 PCR-based Enteric Disease Testing Industry Trends
2.3.2 PCR-based Enteric Disease Testing Market Drivers
2.3.3 PCR-based Enteric Disease Testing Market Challenges
2.3.4 PCR-based Enteric Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR-based Enteric Disease Testing Players by Revenue
3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2019-2024)
3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue
3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio
3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2023
3.5 PCR-based Enteric Disease Testing Key Players Head office and Area Served
3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service
3.7 Date of Enter into PCR-based Enteric Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR-based Enteric Disease Testing Breakdown Data by Type
4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2025-2030)
5 PCR-based Enteric Disease Testing Breakdown Data by Application
5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PCR-based Enteric Disease Testing Market Size (2019-2030)
6.2 North America PCR-based Enteric Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PCR-based Enteric Disease Testing Market Size by Country (2019-2024)
6.4 North America PCR-based Enteric Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PCR-based Enteric Disease Testing Market Size (2019-2030)
7.2 Europe PCR-based Enteric Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PCR-based Enteric Disease Testing Market Size by Country (2019-2024)
7.4 Europe PCR-based Enteric Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific PCR-based Enteric Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PCR-based Enteric Disease Testing Market Size (2019-2030)
9.2 Latin America PCR-based Enteric Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PCR-based Enteric Disease Testing Market Size by Country (2019-2024)
9.4 Latin America PCR-based Enteric Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa PCR-based Enteric Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Vela Diagnostics
11.2.1 Vela Diagnostics Company Detail
11.2.2 Vela Diagnostics Business Overview
11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction
11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.2.5 Vela Diagnostics Recent Development
11.3 CorisBioconcept
11.3.1 CorisBioconcept Company Detail
11.3.2 CorisBioconcept Business Overview
11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction
11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.3.5 CorisBioconcept Recent Development
11.4 Meridian Life Science
11.4.1 Meridian Life Science Company Detail
11.4.2 Meridian Life Science Business Overview
11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction
11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.4.5 Meridian Life Science Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction
11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Abbott (ALERE)
11.6.1 Abbott (ALERE) Company Detail
11.6.2 Abbott (ALERE) Business Overview
11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction
11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.6.5 Abbott (ALERE) Recent Development
11.7 bioMerieux SA
11.7.1 bioMerieux SA Company Detail
11.7.2 bioMerieux SA Business Overview
11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction
11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.7.5 bioMerieux SA Recent Development
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Detail
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction
11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.8.5 Trinity Biotech Recent Development
11.9 DiaSorin Molecular
11.9.1 DiaSorin Molecular Company Detail
11.9.2 DiaSorin Molecular Business Overview
11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction
11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.9.5 DiaSorin Molecular Recent Development
11.10 Etta Healthcare (Ovagene Oncology)
11.10.1 Etta Healthcare (Ovagene Oncology) Company Detail
11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview
11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction
11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.10.5 Etta Healthcare (Ovagene Oncology) Recent Development
11.11 ExcitePCR (PositiveID Corporation)
11.11.1 ExcitePCR (PositiveID Corporation) Company Detail
11.11.2 ExcitePCR (PositiveID Corporation) Business Overview
11.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction
11.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.11.5 ExcitePCR (PositiveID Corporation) Recent Development
11.12 Flow Alliance
11.12.1 Flow Alliance Company Detail
11.12.2 Flow Alliance Business Overview
11.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction
11.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.12.5 Flow Alliance Recent Development
11.13 Fluid-Screen
11.13.1 Fluid-Screen Company Detail
11.13.2 Fluid-Screen Business Overview
11.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction
11.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.13.5 Fluid-Screen Recent Development
11.14 FluimediX
11.14.1 FluimediX Company Detail
11.14.2 FluimediX Business Overview
11.14.3 FluimediX PCR-based Enteric Disease Testing Introduction
11.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.14.5 FluimediX Recent Development
11.15 Fluxergy
11.15.1 Fluxergy Company Detail
11.15.2 Fluxergy Business Overview
11.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction
11.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.15.5 Fluxergy Recent Development
11.16 Focus Diagnostics (DiaSorin Molecular)
11.16.1 Focus Diagnostics (DiaSorin Molecular) Company Detail
11.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview
11.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction
11.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Development
11.17 Future Horizon Scientific
11.17.1 Future Horizon Scientific Company Detail
11.17.2 Future Horizon Scientific Business Overview
11.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction
11.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.17.5 Future Horizon Scientific Recent Development
11.18 Genalyte
11.18.1 Genalyte Company Detail
11.18.2 Genalyte Business Overview
11.18.3 Genalyte PCR-based Enteric Disease Testing Introduction
11.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.18.5 Genalyte Recent Development
11.19 GeneFluidics
11.19.1 GeneFluidics Company Detail
11.19.2 GeneFluidics Business Overview
11.19.3 GeneFluidics PCR-based Enteric Disease Testing Introduction
11.19.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.19.5 GeneFluidics Recent Development
11.20 GenSpeed Biotech
11.20.1 GenSpeed Biotech Company Detail
11.20.2 GenSpeed Biotech Business Overview
11.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction
11.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.20.5 GenSpeed Biotech Recent Development
11.21 Gulf Bio Analytical
11.21.1 Gulf Bio Analytical Company Detail
11.21.2 Gulf Bio Analytical Business Overview
11.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction
11.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.21.5 Gulf Bio Analytical Recent Development
11.22 Hahn-Schickard
11.22.1 Hahn-Schickard Company Detail
11.22.2 Hahn-Schickard Business Overview
11.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction
11.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.22.5 Hahn-Schickard Recent Development
11.23 Helvoet
11.23.1 Helvoet Company Detail
11.23.2 Helvoet Business Overview
11.23.3 Helvoet PCR-based Enteric Disease Testing Introduction
11.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.23.5 Helvoet Recent Development
11.24 HemoCue
11.24.1 HemoCue Company Detail
11.24.2 HemoCue Business Overview
11.24.3 HemoCue PCR-based Enteric Disease Testing Introduction
11.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.24.5 HemoCue Recent Development
11.25 Danaher
11.25.1 Danaher Company Detail
11.25.2 Danaher Business Overview
11.25.3 Danaher PCR-based Enteric Disease Testing Introduction
11.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.25.5 Danaher Recent Development
11.26 IDEX Health&Science
11.26.1 IDEX Health&Science Company Detail
11.26.2 IDEX Health&Science Business Overview
11.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction
11.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.26.5 IDEX Health&Science Recent Development
11.27 iLine Microsystems
11.27.1 iLine Microsystems Company Detail
11.27.2 iLine Microsystems Business Overview
11.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction
11.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.27.5 iLine Microsystems Recent Development
11.28 Inflammatix
11.28.1 Inflammatix Company Detail
11.28.2 Inflammatix Business Overview
11.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction
11.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2019-2024)
11.28.5 Inflammatix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Analyzers/Instruments
Table 3. Key Players of Kits/Panels
Table 4. Global PCR-based Enteric Disease Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global PCR-based Enteric Disease Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global PCR-based Enteric Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global PCR-based Enteric Disease Testing Market Share by Region (2019-2024)
Table 8. Global PCR-based Enteric Disease Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global PCR-based Enteric Disease Testing Market Share by Region (2025-2030)
Table 10. PCR-based Enteric Disease Testing Market Trends
Table 11. PCR-based Enteric Disease Testing Market Drivers
Table 12. PCR-based Enteric Disease Testing Market Challenges
Table 13. PCR-based Enteric Disease Testing Market Restraints
Table 14. Global PCR-based Enteric Disease Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global PCR-based Enteric Disease Testing Market Share by Players (2019-2024)
Table 16. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2023)
Table 17. Ranking of Global Top PCR-based Enteric Disease Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by PCR-based Enteric Disease Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PCR-based Enteric Disease Testing Product Solution and Service
Table 21. Date of Enter into PCR-based Enteric Disease Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PCR-based Enteric Disease Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2019-2024)
Table 25. Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2025-2030)
Table 27. Global PCR-based Enteric Disease Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2019-2024)
Table 29. Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2025-2030)
Table 31. North America PCR-based Enteric Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America PCR-based Enteric Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America PCR-based Enteric Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe PCR-based Enteric Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe PCR-based Enteric Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe PCR-based Enteric Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific PCR-based Enteric Disease Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America PCR-based Enteric Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America PCR-based Enteric Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America PCR-based Enteric Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa PCR-based Enteric Disease Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Detail
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product
Table 49. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. Vela Diagnostics Company Detail
Table 52. Vela Diagnostics Business Overview
Table 53. Vela Diagnostics PCR-based Enteric Disease Testing Product
Table 54. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 55. Vela Diagnostics Recent Development
Table 56. CorisBioconcept Company Detail
Table 57. CorisBioconcept Business Overview
Table 58. CorisBioconcept PCR-based Enteric Disease Testing Product
Table 59. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 60. CorisBioconcept Recent Development
Table 61. Meridian Life Science Company Detail
Table 62. Meridian Life Science Business Overview
Table 63. Meridian Life Science PCR-based Enteric Disease Testing Product
Table 64. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 65. Meridian Life Science Recent Development
Table 66. Bio-Rad Laboratories Company Detail
Table 67. Bio-Rad Laboratories Business Overview
Table 68. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product
Table 69. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 70. Bio-Rad Laboratories Recent Development
Table 71. Abbott (ALERE) Company Detail
Table 72. Abbott (ALERE) Business Overview
Table 73. Abbott (ALERE) PCR-based Enteric Disease Testing Product
Table 74. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 75. Abbott (ALERE) Recent Development
Table 76. bioMerieux SA Company Detail
Table 77. bioMerieux SA Business Overview
Table 78. bioMerieux SA PCR-based Enteric Disease Testing Product
Table 79. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 80. bioMerieux SA Recent Development
Table 81. Trinity Biotech Company Detail
Table 82. Trinity Biotech Business Overview
Table 83. Trinity Biotech PCR-based Enteric Disease Testing Product
Table 84. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 85. Trinity Biotech Recent Development
Table 86. DiaSorin Molecular Company Detail
Table 87. DiaSorin Molecular Business Overview
Table 88. DiaSorin Molecular PCR-based Enteric Disease Testing Product
Table 89. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 90. DiaSorin Molecular Recent Development
Table 91. Etta Healthcare (Ovagene Oncology) Company Detail
Table 92. Etta Healthcare (Ovagene Oncology) Business Overview
Table 93. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product
Table 94. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 95. Etta Healthcare (Ovagene Oncology) Recent Development
Table 96. ExcitePCR (PositiveID Corporation) Company Detail
Table 97. ExcitePCR (PositiveID Corporation) Business Overview
Table 98. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product
Table 99. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 100. ExcitePCR (PositiveID Corporation) Recent Development
Table 101. Flow Alliance Company Detail
Table 102. Flow Alliance Business Overview
Table 103. Flow Alliance PCR-based Enteric Disease Testing Product
Table 104. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 105. Flow Alliance Recent Development
Table 106. Fluid-Screen Company Detail
Table 107. Fluid-Screen Business Overview
Table 108. Fluid-Screen PCR-based Enteric Disease Testing Product
Table 109. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 110. Fluid-Screen Recent Development
Table 111. FluimediX Company Detail
Table 112. FluimediX Business Overview
Table 113. FluimediX PCR-based Enteric Disease Testing Product
Table 114. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 115. FluimediX Recent Development
Table 116. Fluxergy Company Detail
Table 117. Fluxergy Business Overview
Table 118. Fluxergy PCR-based Enteric Disease Testing Product
Table 119. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 120. Fluxergy Recent Development
Table 121. Focus Diagnostics (DiaSorin Molecular) Company Detail
Table 122. Focus Diagnostics (DiaSorin Molecular) Business Overview
Table 123. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product
Table 124. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 125. Focus Diagnostics (DiaSorin Molecular) Recent Development
Table 126. Future Horizon Scientific Company Detail
Table 127. Future Horizon Scientific Business Overview
Table 128. Future Horizon Scientific PCR-based Enteric Disease Testing Product
Table 129. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 130. Future Horizon Scientific Recent Development
Table 131. Genalyte Company Detail
Table 132. Genalyte Business Overview
Table 133. Genalyte PCR-based Enteric Disease Testing Product
Table 134. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 135. Genalyte Recent Development
Table 136. GeneFluidics Company Detail
Table 137. GeneFluidics Business Overview
Table 138. GeneFluidics PCR-based Enteric Disease Testing Product
Table 139. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 140. GeneFluidics Recent Development
Table 141. GenSpeed Biotech Company Detail
Table 142. GenSpeed Biotech Business Overview
Table 143. GenSpeed Biotech PCR-based Enteric Disease Testing Product
Table 144. GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 145. GenSpeed Biotech Recent Development
Table 146. Gulf Bio Analytical Company Detail
Table 147. Gulf Bio Analytical Business Overview
Table 148. Gulf Bio Analytical PCR-based Enteric Disease Testing Product
Table 149. Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 150. Gulf Bio Analytical Recent Development
Table 151. Hahn-Schickard Company Detail
Table 152. Hahn-Schickard Business Overview
Table 153. Hahn-Schickard PCR-based Enteric Disease Testing Product
Table 154. Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 155. Hahn-Schickard Recent Development
Table 156. Helvoet Company Detail
Table 157. Helvoet Business Overview
Table 158. Helvoet PCR-based Enteric Disease Testing Product
Table 159. Helvoet Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 160. Helvoet Recent Development
Table 161. HemoCue Company Detail
Table 162. HemoCue Business Overview
Table 163. HemoCue PCR-based Enteric Disease Testing Product
Table 164. HemoCue Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 165. HemoCue Recent Development
Table 166. Danaher Company Detail
Table 167. Danaher Business Overview
Table 168. Danaher PCR-based Enteric Disease Testing Product
Table 169. Danaher Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 170. Danaher Recent Development
Table 171. IDEX Health&Science Company Detail
Table 172. IDEX Health&Science Business Overview
Table 173. IDEX Health&Science PCR-based Enteric Disease Testing Product
Table 174. IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 175. IDEX Health&Science Recent Development
Table 176. iLine Microsystems Company Detail
Table 177. iLine Microsystems Business Overview
Table 178. iLine Microsystems PCR-based Enteric Disease Testing Product
Table 179. iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 180. iLine Microsystems Recent Development
Table 181. Inflammatix Company Detail
Table 182. Inflammatix Business Overview
Table 183. Inflammatix PCR-based Enteric Disease Testing Product
Table 184. Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2019-2024) & (US$ Million)
Table 185. Inflammatix Recent Development
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PCR-based Enteric Disease Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global PCR-based Enteric Disease Testing Market Share by Type: 2023 VS 2030
Figure 3. Analyzers/Instruments Features
Figure 4. Kits/Panels Features
Figure 5. Global PCR-based Enteric Disease Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global PCR-based Enteric Disease Testing Market Share by Application: 2023 VS 2030
Figure 7. Clostridium Difficile Case Studies
Figure 8. Campylobacteriosis Case Studies
Figure 9. Cholera Case Studies
Figure 10. E. coli Infection Case Studies
Figure 11. H. pylori Infection Case Studies
Figure 12. Salmonellosis Case Studies
Figure 13. Shigellosis Case Studies
Figure 14. Rotavirus Infection Case Studies
Figure 15. Norovirus Infection Case Studies
Figure 16. Parasitic Enteric Disease Case Studies
Figure 17. PCR-based Enteric Disease Testing Report Years Considered
Figure 18. Global PCR-based Enteric Disease Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global PCR-based Enteric Disease Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global PCR-based Enteric Disease Testing Market Share by Region: 2023 VS 2030
Figure 21. Global PCR-based Enteric Disease Testing Market Share by Players in 2023
Figure 22. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by PCR-based Enteric Disease Testing Revenue in 2023
Figure 24. North America PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America PCR-based Enteric Disease Testing Market Share by Country (2019-2030)
Figure 26. United States PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe PCR-based Enteric Disease Testing Market Share by Country (2019-2030)
Figure 30. Germany PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific PCR-based Enteric Disease Testing Market Share by Region (2019-2030)
Figure 38. China PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America PCR-based Enteric Disease Testing Market Share by Country (2019-2030)
Figure 46. Mexico PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa PCR-based Enteric Disease Testing Market Share by Country (2019-2030)
Figure 50. Turkey PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia PCR-based Enteric Disease Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 53. Vela Diagnostics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 54. CorisBioconcept Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 55. Meridian Life Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 57. Abbott (ALERE) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 58. bioMerieux SA Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 59. Trinity Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 60. DiaSorin Molecular Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 61. Etta Healthcare (Ovagene Oncology) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 62. ExcitePCR (PositiveID Corporation) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 63. Flow Alliance Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 64. Fluid-Screen Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 65. FluimediX Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 66. Fluxergy Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 67. Focus Diagnostics (DiaSorin Molecular) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 68. Future Horizon Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 69. Genalyte Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 70. GeneFluidics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 71. GenSpeed Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 72. Gulf Bio Analytical Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 73. Hahn-Schickard Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 74. Helvoet Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 75. HemoCue Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 76. Danaher Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 77. IDEX Health&Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 78. iLine Microsystems Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 79. Inflammatix Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2019-2024)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’